A study to assess the sex differences in treatment and in-hospital outcomes among patients with non-ST-segment elevation myocardial infarction (NSTEMI)
Latest Information Update: 30 Jun 2021
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary) ; ACE inhibitors; Angiotensin receptor antagonists; Aspirin; Beta-adrenergic receptor antagonists; HMG-CoA reductase inhibitors
- Indications Myocardial infarction
- Focus Therapeutic Use
- 30 Jun 2021 New trial record
- 17 May 2021 Results presented at the 70th Annual Scientific Session of the American College of Cardiology